A detailed history of Bnp Paribas transactions in Pfizer Inc stock. As of the latest transaction made, Bnp Paribas holds 287,579 shares of PFE stock, worth $7.6 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
287,579
Previous 192,456 49.43%
Holding current value
$7.6 Million
Previous $5.57 Billion 99.86%
% of portfolio
0.33%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$24.8 - $30.19 $2.36 Million - $2.87 Million
95,123 Added 49.43%
287,579 $7.63 Million
Q3 2024

Nov 13, 2024

BUY
$27.7 - $31.39 $116,423 - $131,932
4,203 Added 2.23%
192,456 $5.57 Billion
Q2 2024

Aug 13, 2024

SELL
$25.26 - $29.6 $747,140 - $875,508
-29,578 Reduced 13.58%
188,253 $5.27 Billion
Q1 2024

May 01, 2024

BUY
$25.89 - $29.73 $5.64 Million - $6.48 Million
217,831 New
217,831 $6.05 Billion

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Bnp Paribas Portfolio

Follow Bnp Paribas and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bnp Paribas, based on Form 13F filings with the SEC.

News

Stay updated on Bnp Paribas with notifications on news.